Griseofulvin
Overview
Dydrogesterone used in the treatment of menstrual disorders such as endometriosis.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Plasma protien binding is 97%. Renal Excretion accounts for > 60% and plasma half life is 6 hr.
Back to top
Contraindications
Back to top
Drug Interactions
No data regarding the interactions of Dydrogesterone was found.
Back to top
Side Effects
Back to top
Dosage
Griseofulvin's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 500 to 1000 mg | 750 (750) | 24 hourly | PO | |
Paedriatic Dosage (20kg)
|
| 10 mg/kg | 10 (10) | 24 hourly | Oral | - |
Neonatal Dosage (3kg)
|
| 10 mg/kg | 10 (10) | 24 hourly | Oral | |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Griseofulvin
Back to top
Previous Drug Generic - Next Drug Generic